1. Strategies to prevent adverse outcomes following Clostridioides difficile infection in the elderly
- Author
-
Margaret A. Olsen, Adriana M Rauseo, Erik R. Dubberke, and Kimberly A. Reske
- Subjects
0301 basic medicine ,Microbiology (medical) ,medicine.medical_specialty ,genetic structures ,Adverse outcomes ,business.industry ,Transmission (medicine) ,030106 microbiology ,Microbiology ,03 medical and health sciences ,0302 clinical medicine ,Infectious Diseases ,Susceptible individual ,Supportive psychotherapy ,Virology ,Epidemiology ,medicine ,Antimicrobial stewardship ,Infection control ,030212 general & internal medicine ,Intensive care medicine ,business ,Clostridioides - Abstract
Introduction: Clostridioides difficile remains the most common cause of healthcare-associated infections in the US, and it disproportionately affects the elderly. Older patients are more susceptible and have a greater risk of adverse outcomes from C. difficile infection (CDI), despite advances in treatment and prevention.Areas covered: The epidemiology and pathogenesis of CDI, as well as risk factors in the aging host, will be reviewed. The importance of antimicrobial stewardship and infection prevention in order to avoid acquisition and transmission will be discussed, as well as strategies to prevent adverse outcomes and recurrent CDI, through optimization of CDI treatment s,election.Expert opinion: Appropriate CDI-prevention strategies to avoid adverse outcomes in this susceptible population involve antimicrobial stewardship and methods to prevent C. difficile transmission in healthcare settings. Management strategies to prevent adverse outcomes include initiation of supportive therapy and proper selection of CDI specific treatments. Many patients may also benefit from adjunctive therapies or additional procedures.
- Published
- 2020
- Full Text
- View/download PDF